{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:10:29Z","timestamp":1789564229558,"version":"build-2803163510"},"reference-count":35,"publisher":"Harborside Press, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Survivors of hematopoietic cell transplantation (HCT) have an increased risk of skin cancer, yet adherence to recommended skin self-examination (SSE) and annual physician skin examinations is low. Scalable strategies to improve screening in this high-risk population are needed.\n                    <jats:bold>Patients and Methods:<\/jats:bold>\n                    We conducted a randomized controlled trial of 720 adult survivors of HCT enrolled between October 30, 2020, and December 13, 2023. Participants received remotely delivered print materials and 12 educational text messages over 9 months (patient activation and education [PAE]). In the PAE plus physician activation group (PAE + Phys), providers also received educational materials and guidance on performing skin examinations. Primary outcomes were participant-reported SSE within the prior 2 months and physician skin examination within the prior 12 months, assessed at baseline and 12 months. Secondary outcomes included the number of body regions examined and skin cancer knowledge.\n                    <jats:bold>Results:<\/jats:bold>\n                    Median age at enrollment was 61 years (range, 18\u201381), and the median time from HCT until enrollment was 3.1 years (range, 1.7\u20135.3). The proportion of participants reporting both physician skin examination and SSE increased in both groups, from 15.8% to 47.5% in the PAE group (odds ratio [OR], 4.98; 95% CI, 3.54\u20137.02) and from 18.0% to 52.1% in the PAE + Phys group (OR, 5.49; 95% CI, 4.03\u20137.50), with no significant between-group difference. SSE increased significantly in both groups, from 34.7% to 81.5% in the PAE group and from 31.5% to 79.0% in the PAE + Phys group, without no significant between-group difference. Physician skin examinations increased from 32.1% to 55.3% in the PAE group and from 33.2% to 64.8% in the PAE + Phys group, with a significantly greater increase in the PAE + Phys group (\n                    <jats:italic>P<\/jats:italic>\n                    =.01). The mean number of body regions examined more than doubled in both groups, and skin cancer knowledge and self-efficacy improved significantly.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Remotely delivered interventions improved skin cancer screening among HCT survivors. Patient activation substantially increased SSE, whereas physician activation provided additional benefit for physician-performed skin examinations. These findings suggest that physician activation enhances clinician-performed screening and supports scalable survivorship care models for high-risk populations.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>ClinicalTrials.gov identifier:<\/jats:bold>\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04358276?term=NCT04358276&amp;draw=2&amp;rank=1\">NCT04358276<\/jats:ext-link>\n                  <\/jats:p>","DOI":"10.6004\/jnccn.2026.7030","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:15:04Z","timestamp":1786022104000},"source":"Crossref","is-referenced-by-count":0,"title":["Technology-Enabled Patient and Physician Activation to Enhance Skin Cancer Screening After HCT: A Randomized Controlled Trial"],"prefix":"10.6004","volume":"24","author":[{"given":"Saro H.","family":"Armenian","sequence":"first","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysia","family":"Bosworth","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Rodarte","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Balasian","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samhitha","family":"Boyapalli","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Herrera","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Echevarria","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanie","family":"Lindenfeld","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monzr","family":"Al Malki","sequence":"additional","affiliation":[{"name":"Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badri","family":"Modi","sequence":"additional","affiliation":[{"name":"Department of Surgery, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Oeffinger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Community and Family Medicine and Population Health Sciences, Duke Cancer Institution, Duke, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Emmons","sequence":"additional","affiliation":[{"name":"Department of Social and Behavioral Sciences, Harvard TH Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashfaq A.","family":"Marghoob","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[{"name":"Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Lennie","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Population Sciences, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Geller","sequence":"additional","affiliation":[{"name":"Department of Social and Behavioral Sciences, Harvard TH Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"N Engl J Med","first-page":"1813","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan EA","year":"2006","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354:1813\u20131826."},{"key":"B2","series-title":"J Clin Oncol","first-page":"3278","article-title":"Burden of long-term morbidity borne by survivors of acute myeloid leukemia treated with blood or marrow transplantation: the results of the BMT survivor study","volume":"40","author":"Armenian SH","year":"2022","unstructured":"Armenian SH, Chen Y, Hageman L,  Burden of long-term morbidity borne by survivors of acute myeloid leukemia treated with blood or marrow transplantation: the results of the BMT survivor study. J Clin Oncol 2022;40:3278\u20133288."},{"key":"B3","series-title":"Blood","first-page":"1302","article-title":"How I monitor long-term and late effects after blood or marrow transplantation","volume":"130","author":"Bhatia S","year":"2017","unstructured":"Bhatia S, Armenian SH, Landier W. How I monitor long-term and late effects after blood or marrow transplantation. Blood 2017;130:1302\u20131314."},{"key":"B4","series-title":"JAMA Oncol","first-page":"1626","article-title":"Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation over 4 decades: a blood or marrow transplant survivor study report","volume":"7","author":"Bhatia S","year":"2021","unstructured":"Bhatia S, Dai C, Landier W,  Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation over 4 decades: a blood or marrow transplant survivor study report. JAMA Oncol 2021;7:1626\u20131634."},{"key":"B5","series-title":"Curr Treat Options Oncol","first-page":"9","article-title":"Second malignancies after hematopoietic stem cell transplantation","volume":"19","author":"Danylesko I","year":"2018","unstructured":"Danylesko I, Shimoni A. Second malignancies after hematopoietic stem cell transplantation. Curr Treat Options Oncol 2018;19:9."},{"key":"B6","series-title":"Biol Blood Marrow Transplant","first-page":"1073","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun CL","year":"2013","unstructured":"Sun CL, Kersey JH, Francisco L,  Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transplant 2013;19:1073\u20131080."},{"key":"B7","series-title":"J Clin Oncol","first-page":"2208","article-title":"Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin\u2019s lymphoma","volume":"23","author":"Brown JR","year":"2005","unstructured":"Brown JR, Yeckes H, Friedberg JW,  Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin\u2019s lymphoma. J Clin Oncol 2005;23:2208\u20132214."},{"key":"B8","series-title":"Transplant Cell Ther.","article-title":"Incidence and risk factors of skin cancer and preneoplastic lesions after autologous and allogeneic hematopoietic cell transplantation","author":"Mansilla-Polo M","year":"2025","unstructured":"Mansilla-Polo M, Montoro J, Lopez-Davia J,  Incidence and risk factors of skin cancer and preneoplastic lesions after autologous and allogeneic hematopoietic cell transplantation. Transplant Cell Ther. Published online July 5, 2025. doi:10.1016\/j.jtct.2025.06.031"},{"key":"B9","series-title":"Bone Marrow Transplant","first-page":"1013","article-title":"Secondary solid cancer screening following hematopoietic cell transplantation","volume":"50","author":"Inamoto Y","year":"2015","unstructured":"Inamoto Y, Shah NN, Savani BN,  Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant 2015;50:1013\u20131023."},{"key":"B10","series-title":"J Clin Oncol","first-page":"1119","article-title":"Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation","volume":"24","author":"Leisenring W","year":"2006","unstructured":"Leisenring W, Friedman DL, Flowers ME,  Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol 2006;24:1119\u20131126."},{"key":"B11","series-title":"JAMA Dermatol","first-page":"775","article-title":"Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review","volume":"151","author":"DePry JL","year":"2015","unstructured":"DePry JL, Vyas R, Lazarus HM,  Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review. JAMA Dermatol 2015;151:775\u2013782."},{"key":"B12","series-title":"Bone Marrow Transplant","first-page":"51","article-title":"Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation","volume":"35","author":"Hasegawa W","year":"2005","unstructured":"Hasegawa W, Pond GR, Rifkind JT,  Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation. Bone Marrow Transplant 2005;35:51\u201355."},{"key":"B13","series-title":"Blood","first-page":"3802","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study","volume":"105","author":"Curtis RE","year":"2005","unstructured":"Curtis RE, Metayer C, Rizzo JD,  Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005;105:3802\u20133811."},{"key":"B14","series-title":"J Am Acad Dermatol","first-page":"706","article-title":"Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation","volume":"77","author":"Kuklinski LF","year":"2017","unstructured":"Kuklinski LF, Li S, Karagas MR,  Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation. J Am Acad Dermatol 2017;77:706\u2013712."},{"key":"B15","series-title":"J Am Acad Dermatol","first-page":"378","article-title":"Role of graft-versus-host disease in the development of secondary skin cancers in hematopoietic stem cell transplant recipients: a meta-analysis","volume":"79","author":"Rambhia PH","year":"2018","unstructured":"Rambhia PH, Conic RZ, Atanaskova-Mesinkovska N,  Role of graft-versus-host disease in the development of secondary skin cancers in hematopoietic stem cell transplant recipients: a meta-analysis. J Am Acad Dermatol 2018;79:378\u2013380.e3."},{"key":"B16","series-title":"Biol Blood Marrow Transplant","first-page":"1665","article-title":"Graft-versus-host disease: role of inflammation in the development of chromosomal abnormalities of keratinocytes","volume":"16","author":"Sloand EM","year":"2010","unstructured":"Sloand EM, Pfannes L, Ling C,  Graft-versus-host disease: role of inflammation in the development of chromosomal abnormalities of keratinocytes. Biol Blood Marrow Transplant 2010;16:1665\u20131673."},{"key":"B17","series-title":"J Natl Cancer Inst","first-page":"17","article-title":"Screening for cutaneous melanoma by skin self-examination","volume":"88","author":"Berwick M","year":"1996","unstructured":"Berwick M, Begg CB, Fine JA,  Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996;88:17\u201323."},{"key":"B18","series-title":"Int J Cancer","first-page":"450","article-title":"Clinical whole-body skin examination reduces the incidence of thick melanomas","volume":"126","author":"Aitken JF","year":"2010","unstructured":"Aitken JF, Elwood M, Baade PD,  Clinical whole-body skin examination reduces the incidence of thick melanomas. Int J Cancer 2010;126:450\u2013458."},{"key":"B19","series-title":"Cancer","first-page":"5395","article-title":"Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening","volume":"118","author":"Katalinic A","year":"2012","unstructured":"Katalinic A, Waldmann A, Weinstock MA,  Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening. Cancer 2012;118:5395\u20135402."},{"key":"B20","series-title":"Biol Blood Marrow Transplant","first-page":"1968","article-title":"Ascertainment of unmet needs and participation in health maintenance and screening of adult hematopoietic cell transplantation survivors followed in a formal survivorship program","volume":"23","author":"Hahn T","year":"2017","unstructured":"Hahn T, Paplham P, Austin-Ketch T,  Ascertainment of unmet needs and participation in health maintenance and screening of adult hematopoietic cell transplantation survivors followed in a formal survivorship program. Biol Blood Marrow Transplant 2017;23:1968\u20131973."},{"key":"B21","series-title":"Curr Hematol Malig Rep","first-page":"75","article-title":"Managing survivorship after hematopoietic cell transplantation","volume":"18","author":"Khera N","year":"2023","unstructured":"Khera N. Managing survivorship after hematopoietic cell transplantation. Curr Hematol Malig Rep 2023;18:75\u201382."},{"key":"B22","series-title":"BMC Cancer","first-page":"721","article-title":"Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH)","volume":"20","author":"Armenian SH","year":"2020","unstructured":"Armenian SH, Lindenfeld L, Iukuridze A,  Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH). BMC Cancer 2020;20:721."},{"key":"B23","series-title":"Prev Med","first-page":"761","article-title":"Reliability of assessment and circumstances of performance of thorough skin self-examination for the early detection of melanoma in the Check-It-Out Project","volume":"38","author":"Weinstock MA","year":"2004","unstructured":"Weinstock MA, Risica PM, Martin RA,  Reliability of assessment and circumstances of performance of thorough skin self-examination for the early detection of melanoma in the Check-It-Out Project. Prev Med 2004;38:761\u2013765."},{"key":"B24","series-title":"Am J Prev Med","first-page":"169","article-title":"Thorough skin examination for the early detection of melanoma","volume":"17","author":"Weinstock MA","year":"1999","unstructured":"Weinstock MA, Martin RA, Risica PM,  Thorough skin examination for the early detection of melanoma. Am J Prev Med 1999;17:169\u2013175."},{"key":"B25","series-title":"Arch Dermatol","first-page":"869","article-title":"The validity and practicality of sun-reactive skin types I through VI","volume":"124","author":"Fitzpatrick TB","year":"1988","unstructured":"Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869\u2013871."},{"key":"B26","series-title":"Health Serv Res","first-page":"1005","article-title":"Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers","volume":"39","author":"Hibbard JH","year":"2004","unstructured":"Hibbard JH, Stockard J, Mahoney ER,  Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 2004;39:1005\u20131026."},{"key":"B27","series-title":"Prev Med","first-page":"96","article-title":"Impact of provider-patient communication on cancer screening adherence: a systematic review","volume":"93","author":"Peterson EB","year":"2016","unstructured":"Peterson EB, Ostroff JS, DuHamel KN,  Impact of provider-patient communication on cancer screening adherence: a systematic review. Prev Med 2016;93:96\u2013105."},{"key":"B28","series-title":"PLoS One","article-title":"Effect of cervical cancer education and provider recommendation for screening on screening rates: a systematic review and meta-analysis","volume":"12","author":"Musa J","year":"2017","unstructured":"Musa J, Achenbach CJ, O\u2019Dwyer LC,  Effect of cervical cancer education and provider recommendation for screening on screening rates: a systematic review and meta-analysis. PLoS One 2017;12:e0183924."},{"key":"B29","series-title":"Cochrane Database Syst Rev","article-title":"Interventions targeted at women to encourage the uptake of cervical screening","volume":"9","author":"Staley H","year":"2021","unstructured":"Staley H, Shiraz A, Shreeve N,  Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 2021;9:CD002834."},{"key":"B30","series-title":"J Clin Oncol","first-page":"2269","article-title":"Advancing Survivors Knowledge (ASK Study) of skin cancer surveillance after childhood cancer: a randomized controlled trial in the childhood cancer survivor study","volume":"41","author":"Geller AC","year":"2023","unstructured":"Geller AC, Coroiu A, Keske RR,  Advancing Survivors Knowledge (ASK Study) of skin cancer surveillance after childhood cancer: a randomized controlled trial in the childhood cancer survivor study. J Clin Oncol 2023;41:2269\u20132280."},{"key":"B31","series-title":"J Natl Cancer Inst","first-page":"442","article-title":"Personalized risk-stratified cancer follow-up care: its potential for healthier survivors, happier clinicians, and lower costs","volume":"111","author":"Mayer DK","year":"2019","unstructured":"Mayer DK, Alfano CM. Personalized risk-stratified cancer follow-up care: its potential for healthier survivors, happier clinicians, and lower costs. J Natl Cancer Inst 2019;111:442\u2013448."},{"key":"B32","series-title":"CA Cancer J Clin","first-page":"234","article-title":"Implementing personalized pathways for cancer follow-up care in the United States: proceedings from an American Cancer Society-American Society of Clinical Oncology summit","volume":"69","author":"Alfano CM","year":"2019","unstructured":"Alfano CM, Mayer DK, Bhatia S,  Implementing personalized pathways for cancer follow-up care in the United States: proceedings from an American Cancer Society-American Society of Clinical Oncology summit. CA Cancer J Clin 2019;69:234\u2013247."},{"key":"B33","series-title":"JMIR Cancer","article-title":"The impact of digital technology on self-management in cancer: systematic review","volume":"9","author":"Lim DSC","year":"2023","unstructured":"Lim DSC, Kwok B, Williams P,  The impact of digital technology on self-management in cancer: systematic review. JMIR Cancer 2023;9:e45145."},{"key":"B34","series-title":"NPJ Digit Med","first-page":"13","article-title":"Deploying digital health tools within large, complex health systems: key considerations for adoption and implementation","volume":"5","author":"Marwaha JS","year":"2022","unstructured":"Marwaha JS, Landman AB, Brat GA,  Deploying digital health tools within large, complex health systems: key considerations for adoption and implementation. NPJ Digit Med 2022;5:13."},{"key":"B35","series-title":"Curr Oncol Rep","first-page":"593","article-title":"The growing role of digital health tools in the care of patients with cancer: current use, future opportunities, and barriers to effective implementation","volume":"26","author":"Haemmerle R","year":"2024","unstructured":"Haemmerle R, Paludo J, Haddad TC,  The growing role of digital health tools in the care of patients with cancer: current use, future opportunities, and barriers to effective implementation. Curr Oncol Rep 2024;26:593\u2013600."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/9\/article-e267030.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/9\/article-e267030.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/9\/article-e267030.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:53:50Z","timestamp":1789563230000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/9\/article-e267030.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2026.7030","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}